KRYS News and Press, Krystal Biotech Inc. From 10/29/19

Safety data from all patients (Phase 1 and Phase 2) show that B-VEC was well tolerated with no related adverse events reported. Nine out of 10 of the wounds closed completely (100% closure) following initial administrations of B-VEC. The average time to wound closure was 17.4 days....

PITTSBURGH, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat rare skin diseases, today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stoc...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

PITTSBURGH, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin diseases, today announced that Krish S. Krishnan, chairman ...

Gainers:  LATAM Airlines Group (NYSE: LTM ) +30% . Just Energy Group (NYSE: JE ) +26% . Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ) +20% . Tiziana Life Sciences PLC (NASDAQ: TLSA ) +20% . Contango Oil & Gas Company (NYSEMKT: MCF ) +14% . Ra Medical Systems, Inc. (NYSE: R...

Krystal Biotech (NASDAQ: KRYS ) has  received  a Notice of Acceptance from IP Australia for patent application number 2016401692, for its lead product candidate KB103. More news on: Krystal Biotech, Inc., Healthcare stocks news, Read more ...

PITTSBURGH, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin diseases, announced the granting of a new patent for its le...

10x Genomics (NASDAQ: TXG ) initiated with Outperform rating and $70 (16% upside) price target at Evercore ISI. More news on: 10x Genomics, Inc., Aurora Cannabis Inc., Corcept Therapeutics Incorporated, Healthcare stocks news, Stocks on the move, , Read more ...

Editor's note: Seeking Alpha is proud to welcome Miguel Costa Coelho as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » Imagine you...